Treatment of fibromas

This study defines the current modes of treatment of patients with uterine fibromas with a review of the literature. Progesterone treatments appear to be principally used in cases of minor functional symptomatology and we discuss recent studies of mifepristone. GnRH agonists are particularly effecti...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European Journal of Obstetrics and Gynecology 1996-06, Vol.66 (2), p.99-107
Hauptverfasser:	Jourdain, Olivier, Descamps, Philippe, Abusada, Nadim, Ventrillon, Elisabeth, Dallay, Dominique, Lansac, Jacques, Body, Gilles
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological and medical sciences Female Female genital diseases Fibroma GnRH agonist Gonadotropin-Releasing Hormone - agonists Gonadotropin-Releasing Hormone - therapeutic use Gynecology. Andrology. Obstetrics Humans Hysterectomy Hysteroscopy Laparoscopy Leiomyoma - drug therapy Leiomyoma - surgery Medical sciences Myolysis Progesterone Progesterone - therapeutic use Tumors Uterine Neoplasms - drug therapy Uterine Neoplasms - surgery
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	This study defines the current modes of treatment of patients with uterine fibromas with a review of the literature. Progesterone treatments appear to be principally used in cases of minor functional symptomatology and we discuss recent studies of mifepristone. GnRH agonists are particularly effective in preoperative treatment for conservative surgery. The indications and results of hysteroscopic resection and laparoscopic myomectomy are compared to those of classic myomectomy and hysterectomy. The indications for myolysis are discussed.
ISSN:	0301-2115 1872-7654
DOI:	10.1016/0301-2115(96)02416-5